Projects

‘A Randomised controlled trail of Acetazolamide for patients with treatment resistant Schizophrenia’’

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2022 - 2026

Project Lead

Dr Smita desphande , dr divya hegde

Authors

Dr Smitha desphande , dr divya hegde

Project Status

ongoing

Project Type

RCT